Elevated expression of NPAS2 in hepatocellular carcinoma (HCC) triggers CDC25A transactivation, dephosphorylates Bcl-2, and ultimately inhibits apoptosis [16]. This evidence concerns the gene BCL2 and hepatocellular carcinoma.